Description
Metronidazole 400 mg Tablets — A High-Demand Molecule for Your PCD Pharma Franchise Portfolio
METINID-400 is a Metronidazole 400 mg tablet formulation developed for the clinical management of anaerobic bacterial and protozoal infections, one of the most frequently prescribed therapeutic segments across general physicians, gynaecologists, dentists, and surgeons in India. For franchise partners exploring a PCD pharma franchise opportunity, this molecule offers consistent prescription volume, repeat purchase behaviour, and wide acceptance across urban and semi-urban markets, making it a dependable addition to any general range portfolio.
Why Distributors Choose Lxir Medilabs for PCD Pharma Franchise Business
Lxir Medilabs is an ISO and WHO-GMP certified pharmaceutical company based in Panchkula, Haryana, with manufacturing operations in Baddi, Himachal Pradesh. Every batch of METINID-400 is manufactured under monitored quality protocols, ensuring stable therapeutic performance that supports doctor confidence and long-term prescription loyalty. As a PCD pharma franchise company in India, we focus on building genuine field-level trust between our franchise partners and the medical fraternity, backed by consistent supply and quality documentation.
Product Highlights for PCD Franchise Partners
- Composition: Metronidazole 400 mg
- Dosage Form: Tablets
- Pack Size: 10 X 10
- Pack Type: ALU ALU for enhanced product stability and shelf protection
- Therapeutic Segment: Anaerobic and protozoal infection management
- Ideal For: General physicians, chemists, and medical representatives building an anti-infective range
Franchise associates and monopoly-basis distributors interested in expanding their anti-infective line can explore our complete range through our PCD pharma franchise division for product support, marketing inputs, and documentation assistance.
Disclaimer: This product should be prescribed and administered strictly under the supervision of a registered medical practitioner.
